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A B S T R A C T
Basophils, which are the rarest granulocytes, play crucial roles in protective immunity against parasites and
development of allergic disorders. Although immunoglobulin (Ig)E-dependent responses via receptor for IgE
(FcεRI) in basophils have been extensively studied, little is known about cell surface molecules that are
selectively expressed on this cell subset to utilize the elimination in vivo through treatment with monoclonal
antibody (mAb). Since CD200 receptor 3 (CD200R3) was exclusively expressed on basophils and mast cells
(MCs) using a microarray screening, we have generated anti-CD200R3 mAb recognizing CD200R3A. In this
study we examined the expression pattern of CD200R3A on leukocytes, and the inﬂuence of the elimination of
basophils by anti-CD200R3A mAb on allergic responses. Flow cytometric analysis showed that CD200R3A was
primarily expressed on basophils and MCs, but not on other leukocytes. Administration with anti-CD200R3A
mAb led to the prominent speciﬁc depletion of tissue-resident and circulating basophils, but not MCs.
Furthermore, in vivo depletion of basophils ameliorated IgE-mediated systemic and local anaphylaxis. Taken
together, these ﬁndings suggest that CD200R3A is reliable cell surface marker for basophils in vivo, and
targeting this unique molecule with mAb for the elimination of basophils may serve as a novel therapeutic
strategy in ameliorating the allergic diseases.
1. Introduction-
Basophils are the least granulocytes, typically representing less than
1% of blood leukocytes, that have been implicated in the protective
immunity against several pathogens, including parasites, and in the
development of allergic disorders [1–3]. While basophils and mast cells
(MCs) share some characteristics, including expression of the high-
aﬃnity receptor for immunoglobulin (Ig)E (Fcε receptor, FcεR) and
release of allergy-inducing mediators such as histamine, basophils are
distinct from MCs in several aspects, including development and
anatomical localization, and life-span [1–3]. Although these apparent
diﬀerences between basophils and MCs might suggest that they may
have distinct roles in vivo, the literatures on the features of basophils
have been limited owing to their rarity and similarities with MCs.
CD200 receptors (CD200Rs), members of the Ig superfamily, are
composed of ﬁve distinct proteins, CD200R1, CD200R2, CD200R3,
CD200R4, and CD200R5 in mice [4–6]. Although CD200R1 or
CD200R2 has been implicated to function as high- or low-aﬃnity
receptor for CD200, the speciﬁc interaction between other CD200Rs
and CD200 remains to be debated [4–7]. Whereas CD200R1 and
CD200R2 is reportedly expressed on lymphoid cells and myeloid cells,
including T cells, dendritic cells, MCs and basophils, CD200 have
shown to be broadly expressed on a variety of cell types derived from
hematopoietic and non-hematopoietic origins [4–7]. Previous studies
have demonstrated that CD200R1 acts as an inhibitory receptor for
subpopulations of macrophage lineages to control several immune
responses [8,9]. Furthermore, the interaction between CD200 and
CD200R1 reportedly led to the inhibition of degranulation and
cytokine production in MCs and basophils upon FcεR stimulation
[10,11]. Relative to CD200R1 and CD200R2, the characterization of
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the other members of CD200R has not been well addressed.
Unlike other CD200Rs, CD200R3 appears to be mainly expressed
on MCs and basophils with possible eight diﬀerent splice versions
(CD200R3A-H) in terms of variances of extracellular portion and
cytoplasmic tails, and three diﬀerent types of cytoplasmic tails might
inﬂuence the association with an immunoreceptor tyrosine-based
activation motif (ITAM)-bearing signaling adaptor molecules, includ-
ing the Fcγ receptor (FcγR) chain as part of FcεR and both DAP10 and
DAP12 [5,6,12,13]. It has been shown that cross-linking of CD200R3
with mAb (clones Ba91 and Ba103) induced degranulation in MCs and
production of the cytokine in basophils in vitro [12]. However, the
ligand(s) and the precise function(s) of CD200R3 remain still unclear.
Anaphylaxis is a rapid-onset, potentially life-threatening allergic
reaction caused by the excessive release of allergic mediators after
allergen exposure [14,15]. It has been well known that anaphylaxis is
mainly caused by cross-linking of IgE-FcεR complexes on MCs [14,15].
Previous studies have suggested that basophils are one of the major
mediators in the IgG-, but not IgE-mediated systemic anaphylaxis,
distinctively from MCs, in mice when mAb to CD200R3 (clone Ba103)
was used for speciﬁc elimination of basophils in vivo [16].
In this study, we examined the expression pattern of CD200R3A on
leukocytes, and the inﬂuence of the depletion of CD200R3A+ leuko-
cytes on IgE-mediated experimental anaphylaxis, known as passive
systemic anaphylaxis (PSA), in mice by utilizing anti-CD200R3A mAb
(clone 6C4H2) [13]. In addition, we further addressed the role of
CD200R3A in FcεRI-mediated activation of MCs.
2. Materials and methods
2.1. Mice
Female C57BL6/J mice were purchased from CLEA Japan (Tokyo,
Japan). Animals were maintained in speciﬁc pathogen-free conditions
in the animal facility at University of Miyazaki. All experimental
procedures were performed with mice between 7 and 12 weeks of
age in accordance with institutional guidelines of the Animal
Experiment Review Board.
2.2. Cells
To prepare single-cell suspensions from spleen and lung, tissue
samples were digested with collagenase type III (Worthington
Biochemical, Lakewood, NJ) at 37 °C for 40 min, and were ground
between glass slides. Splenocytes were treated with red blood cells
(RBC) lysis buﬀer (Sigma-Aldrich, St. Louis, MO) before suspension.
Bone marrow (BM) cells were ﬂushed from the femurs and tibias. To
prepare peritoneal exudate cells (PEC), the peritoneal cavity was
lavaged with 10 ml of PBS using a 10 ml plastic syringe and 18-gauge
needle. Single-cell suspensions were obtained by forcing through a
100-μm cell strainer (BD Biosciences, San Jose, CA). For preparation of
transfectants expressing mock-green ﬂuorescent protein (GFP) or
CD200Rs-GFP, RBL2H3 cells were retrovirally transfected with
pMX-internal ribosome entry site (IRES)-GFP vector (mock-GFP) as
a control or pMX-CD200Rs-IRES-GFP vectors as described previously
[13]. BM-derived MCs (BMMCs) were generated as previously de-
scribed [12]. Brieﬂy, BM cells were cultured in RPMI-1640 medium
(Wako Pure Chemicals, Osaka, Japan) supplemented with recombinant
murine interleukin (IL)-3 (4 ng/ml, Wako Pure Chemicals), 10% heat
inactivated FBS, antibiotic-antimycotic (GIBCO BRL, Rockville, MD),
1 mM L-glutamine, and 0.05 mM 2-mercaptoethanol for 4 weeks, and
the cell population conﬁrmed by ﬂow cytometry in which
CD49b+FcεRIα+ BMMCs represented 90% of the cells.
2.3. Flow cytometry
Cells were stained with ﬂuorescein-conjugated mAbs to mouse
CD3ε (145-2C11), CD4 (RM4-5), CD8α (53-6.7), CD11b (M1/70),
CD11c (HL3), CD49b (HMα2), B220 (RA3-6B2), CD117 (2B8),
isotype-matched control mAb (BD Biosciences), FcεRIα (MAR-1)
(eBioscience, San Diego, CA). For CD200R3 staining, cells were stained
with biotinylated mAb to CD200R3A (6C4H2), which was generated in
our laboratory as described previously [13], plus streptavidin-PE (BD
Biosciences). For staining with recombinant fusion proteins, cells were
stained with Fc fragment of human IgG (huIgFc) or CD200-huIgFc [13]
followed by anti-human IgG-PE (eBioscience). Fluorescence staining
was analyzed with a FACSCalibur ﬂow cytometer (BD Biosciences) and
FlowJo software (Tree Star, Ashland, OR).
2.4. In vivo depletion of basophils
For the depletion of CD200R3A+ leukocytes in vivo, mice were
intravenously (i.v.) injected with anti-CD200R3A mAb (clone 6C4H2;
100 μg/mouse) or isotype-matched control Ig (100 μg/mouse; Sigma-
Aldrich) through the tail vein one day before the antigenic sensitiza-
tion.
2.5. Degranulation assay
Degranulation of MCs was measured by the release of β-hexosami-
nidase according to the previous report [12,17] with some modiﬁca-
tions. Brieﬂy, BMMCs were incubated overnight with 2,4-dinitrophenol
(DNP)-speciﬁc IgE (clone SPE-7, 1 μg/ml; Sigma-Aldrich) in RPMI-
1640 medium. After overnight incubation, the cells were stimulated
with or without DNP-conjugated bovine serum albumin (DNP-BSA,
250 ng/ml; LSL, Tokyo, Japan) in the presence or absence of isotype-
matched control Ig (10 μg/ml) or anti-CD200R3A mAb (clone 6C4H2;
10 μg/ml), or ionomycin (1 µm; Sigma-Aldrich) at 37 °C for 30 min in
Tyrode's buﬀer. The supernatant was collected to determine the β-
hexosaminidase activity and the cells were lysed with 1%-Triton X
(Wako Pure Chemicals) in Tyrode's buﬀer. The supernatant and lysate
were incubated with p-nitrophenyl N-acetyl β-gulcosaminide (Wako
Pure Chemicals) in citrate buﬀer at 37 °C for an hour. The reaction was
stopped by glycine and absorbance was measured with a spectro-
photometer at 405 nm. The calculation of the release of β-hexosami-
nidase was determined by the following equation: (supernatant optical
density)/(supernatant optical density plus cell lysate optical density)
×100.
2.6. Induction of passive systemic anaphylaxis
Induction and evaluation of passive systemic anaphylaxis were
performed according to the previous report [16] with some modiﬁca-
tions. In brief, mice were i.v. sensitized with DNP-speciﬁc IgE (50 μg in
300 μl PBS/mouse), and then the sensitized mice were injected i.v. with
or without isotype-matched control Ig (100 μg/mouse) or anti-
CD200R3A mAb (clone 6C4H2; 100 μg/mouse) 1 h after sensitization.
Twenty-four hours after sensitization, the mice were i.v. challenged
with DNP-BSA (50 μg in 300 μl PBS/mouse), and rectal temperature
was measured by a digital thermometer (TD-300; Shibaura Electronics,
Tokyo, Japan) every 5 min for 60 min.
2.7. Passive cutaneous anaphylaxis
Induction and evaluation of passive cutaneous anaphylaxis were
performed as described previously [12] with some modiﬁcations. In
brief, mice were intradermally (i.d.) sensitized with or without DNP-
speciﬁc IgE (100 ng in 100 μl PBS/mouse) or control PBS in each ear,
and then the sensitized mice were injected i.v. with or without isotype-
matched control Ig (100 μg/mouse) or anti-CD200R3A mAb (clone
6C4H2; 100 μg/mouse) 1 h after sensitization. Twenty-four hours after
sensitization, the mice were i.v. challenged with DNP-BSA (125 μg in
200 μl PBS/mouse) containing 0.8% Evan's blue dye (Sigma-Aldrich).
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45 min after challenge, mice were sacriﬁced, and both ears were
removed for measurement of vascular leakage of the dye. The dye
was extracted from the ear by incubating N, N-dimethyl-formamide
(Wako Pure Chemicals) at 55 °C for 3 h. The absorbance of the dye was
measured with a spectrophotometer (iMark Microplate Reader; Bio-
Rad, Hercules, CA) at 595 nm.
2.8. Statistical analysis
Data are the means ± s.d. from three to eight individual samples in
a single experiment, and we performed at least four independent
experiments. The statistical signiﬁcance of diﬀerences between groups
was analyzed using Student's t-test (two-tailed). P values < 0.05 or
0.01 were considered statistically signiﬁcant.
3. Results
3.1. CD200R3A mainly expressed on basophils and MCs in vivo
As a microarray screening revealed that CD200R3 was predomi-
nantly expressed on basophils and MCs, we generated mAb against
CD200R3A (clone 6C4H2) [13]. To examine the speciﬁc binding of
anti-CD200R3A mAb (clone 6C4H2) to CD200R3A among CD200Rs,
RBL2H3 cells expressing mock-GFP or CD200Rs-GFP were stained
with anti-CD200R3A mAb (clone 6C4H2). Flow cytometry analysis
showed that anti-CD200R3A mAb (clone 6C4H2) bound to RBL2H3
cells expressing CD200R3A, but not other transfectants (Fig. 1A).
These results indicate that anti-CD200R3A mAb (clone 6C4H2)
speciﬁcally recognizes CD200R3A among CD200R family molecules.
We next examined the binding of CD200 fusion protein, which
consists of the extracellular domain of CD200 and huIgFc (CD200-
huIgFc), to RBL2H3 cells expressing mock-GFP or CD200Rs-GFP
(Fig. 1B). CD200-huIgFc bound to RBL2H3 cells expressing
CD200R1 and CD200R2 to a lesser degree, indicating that CD200 is
a ligand for CD200R1 and CD200R2 with high and low aﬃnities.
However, CD200-huIgFc did not bind to RBL2H3 cells expressing
mock-GFP or other CD200Rs-GFP, suggesting that CD200 could not be
a ligand for CD200R3 and CD200R4.
We addressed the expression pattern of CD200R3A on leukocytes.
Flow cytometry with anti-CD200R3A mAb (clone 6C4H2) showed that
the fractions of FcεRIα+ cells and c-kit+ cells expressed CD200R3A,
whereas CD3+CD4+ T cells, CD3+CD8+ T cells, B220+ B cells,
CD11chigh dendritic cells, and CD11b+CD11c-CD49b- macrophages
did not express this molecule (Fig. 1C). Indeed, the high expression
of CD200R3A was only observed on FcεRIα+CD49b+ basophils and
FcεRIα+c-kit+ MCs, but not other leukocytes (Fig. 1D). These results
indicate that CD200R3A is predominantly expressed on basophils and
MCs among leukocytes.
3.2. The administration of anti-CD200R3A mAb (clone 6C4H2)
eliminates basophils in vivo
To clarify whether the administration with anti-CD200R3A mAb
(clone 6C4H2) could deplete basophils and MCs in vivo, mice were
systemically injected with this mAb, and we quantiﬁed the frequencies
of FcεRIα+CD49b+ basophils and FcεRIα+c-kit+ MCs among leukocytes
in spleen, lung, peripheral blood, and peritoneal cavity. A single
injection with anti-CD200R3A mAb (clone 6C4H2) or anti-FcεRIα
mAb (clone MAR-1) signiﬁcantly ablated FcεRIα+CD49b+ basophils or
CD200R3A+CD49b+ basophils in spleen, lung, and peripheral blood
the next day after the injection (Fig. 2A-D). In contrast, there was no
change in the proportion of FcεRIα+c-kit+ MCs and CD200R3A+c-kit+
MCs in peritoneal cavity after injection with anti-CD200R3A mAb
(clone 6C4H2) or anti-FcεRIα mAb (clone MAR-1) (Fig. 2E-H). A
maximal elimination of FcεRIα+CD49b+ basophils was achieved 24 h
after the injection of anti-CD200R3A mAb (clone 6C4H2), but their
proportion immediately rebounded thereafter, and had fully recovered
by day 3 (Fig. 2I). These results indicate that administration with anti-
CD200R3A mAb (clone 6C4H2) speciﬁcally eliminate basophils, but
not MCs, in vivo.
3.3. Inﬂuence of anti-CD200R3A mAb (clone 6C4H2) on the
activation of MCs
To address the eﬀect of the ligation of CD200R3A by anti-
CD200R3A mAb (clone 6C4H2) on the function of MCs, we performed
a FcεR-mediated degranulation assay in BMMCs (Fig. 3A). In line with
the published reports [12,17], cross-linking of FcεR with anti-DNP IgE
mAb plus DNP-BSA induced the degranulation in BMMCs. On the
other hand, treatment of BMMCs with anti-CD200R3A mAb (clone
6C4H2), but not control Ig, slightly induced the degranulation in
BMMCs as compared with untreated BMMCs, while this treatment
caused a further enhancement of their FcεR-mediated degranulation.
These results indicate that anti-CD200R3A mAb (clone 6C4H2) act as
an agonistic mAb to activate the function of MCs in vitro.
To further examine whether the administration with anti-
CD200R3A mAb (clone 6C4H2) could induce the IgE-independent
systemic anaphylaxis, mice were systemically injected with this mAb,
and we monitored the body temperature of mice every 5 min for
60 min (Fig. 3B). However, the decline of the body temperature was
not observed after the administration of anti-CD200R3 mAb (clone
6C4H2) as well as control Ig. These results indicate that anti-
CD200R3A mAb (clone 6C4H2) does not elicit the IgE-independent
systemic anaphylaxis in vivo.
3.4. Treatment with anti-CD200R3A mAb (clone 6C4H2) ameliorates
IgE-mediated systemic and local anaphylaxis
To determine the protective eﬀect of the administration with anti-
CD200R3A mAb (clone 6C4H2) on IgE-mediated anaphylaxis in vivo,
we evaluated the IgE-mediated systemic and local anaphylactic re-
sponses in the sensitized mice treated with this mAb. Mice that had
been sensitized with DNP-speciﬁc IgE manifested not only systemic
anaphylaxis marked by the decline of the body temperature but also
local anaphylaxis as judged by increased vascular permeability and dye
extravasation after the challenge with DNP-BSA (Fig. 4). In contrast,
treatment of the sensitized mice with anti-CD200R3A mAb (clone
6C4H2), but not control Ig, exhibited the ameliorated systemic
anaphylactic response (Fig. 4A). Furthermore, this treatment led to
the inhibition of the enhanced vascular permeability measured by the
leakage of dye as compared with untreated mice (Fig. 4B and C). Taken
together, these results indicate that the elimination of basophils by the
administration of anti-CD200R3A mAb (clone 6C4H2) protects from
IgE-mediated systemic and local anaphylaxis in vivo.
4. Discussion
In this study, we demonstrate that CD200R3A is a speciﬁc cell
surface molecule for basophils and MCs, and the treatment with anti-
CD200R3A mAb is eﬀective for protecting allergen-sensitized mice
from the IgE-mediated systemic and local anaphylaxis mediated by the
elimination of basophils in vivo.
While FcεRIα has been widely used for the detection of basophils
and MCs in combination with other cell surface molecules (e.g., CD49b
and c-kit), this cell surface molecule is also reportedly expressed on
other cell types [18]. In consistence with the previous observations
[12,13,16], we further conﬁrmed that the expression of CD200R3A was
restricted to basophils and MCs, but not other leukocytes, in various
tissues. Therefore, CD200R3A is reliable cell surface marker for the
detection of basophils and MCs in vivo. Accordingly, the detection of
CD200R3A by anti-CD200R3A mAb (clone 6C4H2) might be useful for
the clariﬁcation of their developmental process and anatomical locali-
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Fig. 1. Expression of CD200R3A on basophils and MCs. (A) Speciﬁc reactivity of mAb to CD200R3A (clone 6C4H2) against RBL2H3 cells expressing mock-GFP or CD200Rs-GFP was
analyzed by ﬂow cytometry, and data are represented by a dot plot. (B) Binding of CD200-huIgFc to RBL2H3 cells expressing mock-GFP and CD200Rs-GFP was analyzed by ﬂow
cytometry, and data are represented by a histogram. (C) The expression of CD200R3A and cell surface molecules on leukocytes was analyzed by ﬂow cytometry with isotype-matched
control Ig or anti-CD200R3A mAb (clone 6C4H2), and data are represented by a dot plot. (D) Cell surface expression of CD200R3A on CD3+CD4+ T cells, CD3+CD8+ T cells, B220+ B
cells, CD11chigh dendritic cells, CD11b+CD11c-CD49b- macrophages, FcεRIα+CD49b+ basophils, and FcεRIα+c-kit+ MCs were analyzed by ﬂow cytometry with isotype-matched control
Ig or anti-CD200R3A mAb (clone 6C4H2), and data are represented by a histogram. Data are representative of four independent experiments with similar results.
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zation under physiological and pathological conditions.
Whereas one way to analyze FcεRIα+CD49b+ basophils and
FcεRIα+c-kit+ MCs in vivo is to delete them through treatment with
anti-FcεRIα mAb (clone MAR-1), this approach remains problematic
because FcεRIα is also expressed on other leukocytes, resulting in the
depletion of additional cell types. Similar to the previous reports with
anti-CD200R3 mAb (clone Ba103) [16,19], the administration with
anti-CD200R3A mAb (clone 6C4H2) led to the prominent in vivo
depletion of CD200R3A+FcεRIα+CD49b+ basophils, but not
CD200R3A+FcεRIα+c-kit+ MCs. The reason why the injection with
anti-CD200R3 mAb (clones 6C4H2 andBa103) failed to deplete MCs
remains unclear despite similar expression level of CD200R3 on
basophils and MCs, this diﬀerence might be explained by their
sensitivities to the Ab-dependent cellular cytotoxicity and FcγR–
mediated phagocytosis as well as anatomical localization and life-span.
Collectively, these ﬁnding suggest that the use of anti-CD200R3A mAb
Fig. 3. Inﬂuence of the treatment with anti-CD200R3A mAb on IgE-dependent degranulation in MCs and induction of systemic anaphylaxis. (A) BMMCs were incubated with or
without DNP-speciﬁc IgE, and then stimulated with DNP-BSA in the presence or absence of isotype-matched control Ig or anti-CD200R3A mAb (clone 6C4H2), or ionomycin as a
positive control. β-hexosaminidase release was measured for the indication of MC degranulation. Data are the percentage of degranulated MCs among whole cells ± s.d. from four to
eight individual samples in a single experiment. *P < 0.05 compared with untreated cells or among groups. (B) Mice were injected with control IgG (n=3) or anti-CD200R3A mAb (clone
6C4H2; n=3). Rectal temperature was monitored every 5 min for 60 min after the injection. Data are the mean ± s.d. from three individual samples in a single experiment. Data are
Fig. 4. Amelioration of IgE-mediated passive anaphylaxis by the administration of anti-CD200R3A mAb. (A) Mice that had been systemically sensitized with DNP-speciﬁc IgE were
injected with or without isotype-matched control Ig or anti-CD200R3A mAb (clone 6C4H2; n=3) one hour after sensitization. Twenty-four hours after sensitization, mice were
systemically challenged with DNP-BSA, and rectal temperature was monitored every 5 min for 60 min after antigenic challenge. Data are the mean ± s.d. from three individual samples
in a single experiment. *P < 0.05 compared with untreated control. (B and C) Mice that had been sensitized with or without DNP-speciﬁc IgE in each ear were injected with or without
isotype-matched control Ig or anti-CD200R3A mAb (clone 6C4H2; n=3) one hour after sensitization. Twenty-four hours after sensitization, mice were systemically challenged with DNP-
BSA containing 0.8% Evan's blue dye. Forty ﬁve minutes after challenge, the photographs of the ears were taken (B) and the amount of vascular leakage was measured (C). Data are the
mean ± s.d. from three individual samples in a single experiment. *P < 0.01 compared with untreated control. Data are representative of four independent experiments with similar
results.
Fig. 2. In vivo depletion of basophils by the administration of anti-CD200R3A mAb. (A-I) Mice were injected with control IgG (A-I), anti-CD200R3A mAb (clone 6C4H2; A, B, E, and
F), or anti-FcεRIα mAb (clone MAR-1; C, D, G, and H), and spleen, lung, peripheral blood, PEC were obtained next day after the injection. The frequency of basophils or MCs was
analyzed by ﬂow cytometry. (A, C, E, and G) Data are represented by a dot plot, and numbers represent the proportion of FcεRIα+CD49b+ basophils (A) or CD200R3A+CD49b+
basophils (C) or FcεRIα+c-kit+ MCs (E) or CD200R3A+c-kit+ MCs (G) among leukocytes in each quadrant. (B, D, F, andH) Data are the mean percentage of FcεRIα+CD49b+ basophils
(B) or CD200R3A+CD49b+ basophils (D) or FcεRIα+c-kit+ MCs (F) or CD200R3A+c-kit+ MCs (H) among leukocytes ± s.d. from three individual samples in a single experiment. *P <
0.05 compared with control IgG. (I) Mice were injected with control IgG or anti-CD200R3A mAb (clone 6C4H2), and spleen, lung, peripheral blood, PEC were obtained at the indicated
days after the injection. The frequency of basophils or MCs was analyzed by ﬂow cytometry. Data are the percentage of FcεRIα+CD49b+ basophils or FcεRIα+c-kit+ MCs among
leukocytes ± s.d. from three individual samples in a single experiment. *P < 0.05 compared with control IgG. Data are representative of four independent experiments with similar
results.
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provides advantageous means to analyze in vivo unique function of
basophils.
As anti-CD200R3 mAbs (clones Ba91 and Ba103) recognized both
CD200R3A and CD200R3G, stimulation with these mAbs strongly
activated basophils and MCs to degranulate and produce cytokine in
vitro possibly mediated through the association of CD200R3 (isoforms
A and G) with ITAM-bearing DAP12 and the activation of its down-
stream signaling cascades [12]. Furthermore, the injections with anti-
CD200R3 mAbs (clones Ba91 and Ba103) caused IgE-independent
systemic and local anaphylaxis in mice. Whereas the ligation of
CD200R3A by anti-CD200R3A mAb (clone 6C4H2) slightly induced
the degranulation in MCs, this treatment potentiated their FcεR-
mediated activation. We also observed that the administration with
anti-CD200R3A mAb (clone 6C4H2) did not enhance IgE-dependent
systemic and local anaphylactic responses in vivo possibly owing to
their ability to eliminate CD200R3+ leukocytes, such as basophils and
MCs, prior to their activation. The discrepancies on the functions of
these CD200R3 mAbs might be due to their distinct recognition of
CD200R3 isoforms exerting diﬀerent function and epitopes or binding
aﬃnities. Given that basophils and MCs play crucial roles in the host
defense against pathogens, such as parasites [1–3], CD200R3 might act
as an activating receptor that recognizes certain pathogen-associated
molecular patterns, independent of or synergistically with IgE-FcεR-
mediated cellular activation. Further study will be needed to test this
possibility.
Previous studies has shown that the depletion of basophils by anti-
CD200R3 mAbs (clone Ba103) attenuated IgG-mediated systemic
anaphylaxis, whereas this treatment had not eﬀect on IgE-mediated
systemic anaphylaxis in mice, suggesting that basophils are one of the
major players in the IgG-mediated systemic anaphylaxis, but not IgE-
mediated systemic anaphylaxis, while MCs are crucial for the develop-
ment of IgE-mediated systemic anaphylaxis [14,16]. On the other
hand, analysis of Mcpt8Cre-transgenic mice suggested that basophils
were not required for passive IgE- or IgG1-mediated systemic anaphy-
laxis, whereas they were essential for IgE-mediated chronic allergic
inﬂammation and protective immunity against secondary helminth
infection [20]. We showed that the ablation of basophils, but not MCs,
by anti-CD200R3A mAb (clone 6C4H2) ameliorated IgE-mediated
systemic and local anaphylaxis in vivo. As anti-CD200R3A mAb (clone
6C4H2) and anti-CD200R3 mAbs (clone Ba103) [16,19] could exhibit
a similar eﬃciency of depletion of basophils in vivo, the diﬀerence in
CD200R3 isoforms with individual function and their epitopes recog-
nized by these mAbs might explain the discrepancy on the mAb-
mediated depletion of basophils on IgE-mediated systemic and local
anaphylaxis in vivo. Therefore, the disparity among these observations
regarding the role of basophils in IgE- or IgG1-mediated systemic
anaphylaxis might be inﬂuenced by experimental conditions, such as
mouse strains, experimental designs, and environmental factors. Taken
together, our ﬁndings suggest that CD200R3A+FcεRIα+CD49b+ baso-
phils as well as MCs participate in the induction of IgE-mediated
systemic and local anaphylaxis under certain conditions in vivo.
In conclusion, we described that CD200R3A are predominantly
expressed on basophils and MCs, and it potentially functions as
activating receptor on these cell type. Furthermore, the application
with anti-CD200R3A mAb (clone 6C4H2) is eﬀective for the ameliora-
tion of IgE-mediated anaphylaxis. Thus, targeting this unique human
orthologue with mAb may constitute new therapy for basophil-
mediated allergic disorders.
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